Göteborg University
gu.seTotal trials
267
Active
61
Phase 3
17
Total enrollment
70,817
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| GDMT | — | — | — | — | — | 1 | |
| OSU6162 | — | — | — | — | — | 2 | |
| Ixekizumab | — | — | — | — | — | 1 | |
| Dexmedetomidine | — | — | — | — | — | 1 | |
| Esketamine | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | — | 1 | |
| Remifentanil | — | — | — | — | — | 1 | |
| Desflurane | — | — | — | — | — | 1 | |
| Propofol | — | — | — | — | — | 1 | |
| Oxycodone | — | — | — | — | — | 1 | |
| Medical treatment | — | — | — | — | — | 1 |
Next readouts
- 2024-08-26
- 2026-05-31
- 2026-05-31
- 2027-02
- 2028-05-28
- 2028-05-31
Top conditions
- Obesity16
- Stroke8
- Hypertension7
- Fibromyalgia6
- Physical Activity6
- Peri-Implantitis5
- Inflammation5
- Chronic Pain5
Frequently asked questions about Göteborg University
- How many clinical trials does Göteborg University have on ClinicalTrials.gov?
- Göteborg University is listed as the lead sponsor on 267 clinical trials in ClinicalTrials.gov, 61 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Göteborg University's trials are in Phase 3?
- 17 of Göteborg University's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does Göteborg University focus on?
- Göteborg University's most-studied conditions on ClinicalTrials.gov are Obesity, Stroke, Hypertension, Fibromyalgia, Physical Activity.
- When are Göteborg University's next clinical trial readouts?
- Göteborg University has 6 upcoming primary-completion readouts tracked here; the soonest is “Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction”, expected around 2024-08-26.